A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia.

ABSTRACT:

SUBMITTER: Short NJ 

PROVIDER: S-EPMC6511975 | biostudies-literature | 2018 Aug

REPOSITORIES: biostudies-literature